PRF1 and neoplasm: The major histocompatibility class I (MHC-I) complex is recognized by KIR receptors inhibiting the activation of NK cells, however, tumor cells display diminished amounts of MHC-I which in consequence triggers the activation of NK cells, with the subsequent release of their cytoplasmic granules containing granzyme and perforin finally inducing cell lysis (135).